DW 1025
Alternative Names: DW-1025Latest Information Update: 05 May 2023
At a glance
- Originator Dong Wha Pharmaceutical
- Class Antiasthmatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Asthma
Most Recent Events
- 20 Apr 2023 Early research in Asthma in South Korea (unspecified route) prior to April 2023 (Dong Wha Pharmaceutical pipeline, April 2023)